to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Receptors, Antigen, T-Cell, alpha-beta
Receptors, Antigen, T-Cell
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.
Active Immunotherapy of Cancer.
CTLA4 blockade broadens the peripheral T-cell receptor repertoire.
Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer.
A rare population of tumor antigen-specific CD4+CD8+ double-positive aß T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells.
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy.
HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized mice.
Cellular Immunotherapy in the Treatment of Hematopoietic Malignancies.
Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses.
Human antigen-specific regulatory T cells generated by T cell receptor gene transfer.
CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model.
T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFß) signaling mediate superior tumor regression in an animal model of adoptive cell therapy.
Adoptive cell transfer of T-cell receptor-engineered lymphocytes: lessons from recent modeling.
Modular nucleic acid assembled p/MHC microarrays for multiplexed sorting of antigen-specific T cells.
Engineering tumor stromal mechanics for improved T cell therapy.
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
Receptors Antigen B Cell